Natural History of Viral Induced Airway Dysfunction and Asthma in Minority Children

少数民族儿童病毒引起的气道功能障碍和哮喘的自然史

基本信息

项目摘要

PROJECT SUMMARY/ABSTRACT Asthma prevalence in Puerto Ricans is 37% versus 12% for whites yet most studies have been conducted among the latter. This asthma burden extends to asthma morbidity and mortality, which are 2.4- and 4-fold higher among Puerto Ricans compared to whites, respectively. There is a strong association between severe, early-life viral respiratory illnesses and development of childhood recurrent wheeze and asthma. However, little is known about the mechanisms underlying these associations. Does airway dysfunction exist at birth and first manifest in early life as a severe illness in response to viral respiratory infections, and later as childhood asthma? Or does a severe, early-life respiratory illness injure a normal airway and precipitate asthma later in childhood? We will study Puerto Rican children to address these questions via three Specific Aims. Aim 1: Recruit a cohort of 3,000 newborns to longitudinally study the effects of early-life viral respiratory illnesses on nasal airway molecular endotype and risk for recurrent wheeze. We will collect yearly environmental, social, and clinical data on each participant and track all respiratory illnesses from birth to age 3. We will record severity and presence of wheezing in each child's illnesses and collect nasal swabs to determine the presence/type of virus associated with these illnesses. Aim 2: Identify viral and genetic determinants of severe early-life respiratory illnesses and whether the molecular state of the nasal airway epithelium at birth is predictive of these severe illnesses. We will perform transcriptomic and viral analyses on nasal airway swabs from subjects at birth and during respiratory illness. We will test if severe respiratory illnesses are associated with viral infection in general and/or infection with a specific viral species. We will use genome-wide genetic data to identify risk variants for severe early-life respiratory illnesses and variants influencing airway gene expression at birth and during illness (eQTLs). We will test for GxE interactions between top risk variants/eQTLs and infection with different viral species. We will also identify gene expression response to mild vs. severe early-life respiratory illnesses and determine if airway gene expression at birth is predictive of severe respiratory illness in early childhood. Aim 3: Determine the relationship between severity of early-life respiratory illness and post-illness but pre-asthma nasal airway gene expression profiles. We will perform transcriptomic and viral metagenomic analysis of nasal swabs collected from subjects at age 3. We will determine how severe respiratory illnesses affect the trajectory of airway gene expression profiles from birth to early childhood. Finally, we will determine if mild or severe respiratory illness in early life is predictive of recurrent wheeze at age 3. Our longitudinal birth cohort will [1] be the largest prospective study of minority infants, [2] provide novel and seminal information on genetic/viral risk factors for severe respiratory illnesses, and [3] identify airway endotypes that high-risk groups exhibit at birth and after respiratory illness, but prior to asthma onset. Our study will help to elucidate the relationship between early-life respiratory illness and asthma.
项目概要/摘要 波多黎各人的哮喘患病率为 37%,而白人的哮喘患病率为 12%,但大多数研究均已进行 其中。这种哮喘负担导致哮喘发病率和死亡率分别是原来的 2.4 倍和 4 倍 与白人相比,波多黎各人的比例分别更高。严重程度之间有很强的关联性, 生命早期的病毒性呼吸道疾病以及儿童反复喘息和哮喘的发展。然而,很少 了解这些关联背后的机制。出生时和刚出生时是否存在气道功能障碍 在生命早期表现为对病毒性呼吸道感染的严重疾病,随后在儿童时期表现为 哮喘?或者,生命早期严重的呼吸系统疾病会损害正常气道并在以后引发哮喘吗? 童年?我们将研究波多黎各儿童,通过三个具体目标来解决这些问题。目标 1: 招募 3,000 名新生儿组成的队列,纵向研究生命早期病毒性呼吸道疾病对新生儿的影响 鼻气道分子内型和反复喘息的风险。我们将收集年度环境、社会、 以及每个参与者的临床数据,并跟踪从出生到 3 岁的所有呼吸道疾病。我们将记录 每个孩子疾病的严重程度和喘息的存在,并收集鼻拭子以确定 与这些疾病相关的病毒的存在/类型。目标 2:确定重症的病毒和遗传决定因素 生命早期呼吸系统疾病以及出生时鼻气道上皮的分子状态是否 可以预测这些严重的疾病。我们将对鼻气道拭子进行转录组和病毒分析 来自出生时和呼吸道疾病期间的受试者。我们将测试是否与严重呼吸道疾病有关 一般病毒感染和/或特定病毒种类感染。我们将使用全基因组遗传 用于识别严重生命早期呼吸系统疾病的风险变异和影响气道基因的变异的数据 出生时和患病期间的表达(eQTL)。我们将测试最高风险之间的 GxE 交互 变异/eQTL 和不同病毒种类的感染。我们还将确定对轻度的基因表达反应 与严重的早期呼吸系统疾病相比,并确定出生时的气道基因表达是否可以预测 儿童早期患有严重的呼吸道疾病。目标 3:确定早年严重程度之间的关系 呼吸系统疾病和病后但哮喘前的鼻气道基因表达谱。我们将表演 对 3 岁时收集的受试者鼻拭子进行转录组和病毒宏基因组分析。我们将 确定严重的呼吸道疾病如何影响从出生到气道基因表达谱的轨迹 幼儿期。最后,我们将确定生命早期的轻微或严重呼吸道疾病是否预示着 3 岁时反复喘息。我们的纵向出生队列将 [1] 成为针对少数族裔的最大的前瞻性研究 婴儿,[2]提供有关严重呼吸道疾病的遗传/病毒危险因素的新颖和开创性的信息, [3] 识别高危人群在出生时和呼吸系统疾病之后、但在患病之前表现出的气道内型 哮喘发作。我们的研究将有助于阐明早期呼吸系统疾病与哮喘之间的关系。

项目成果

期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

Esteban Gonzalez Burchard其他文献

Esteban Gonzalez Burchard的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

{{ truncateString('Esteban Gonzalez Burchard', 18)}}的其他基金

Natural History of Viral Induced Airway Dysfunction and Asthma in Minority Children
少数民族儿童病毒引起的气道功能障碍和哮喘的自然史
  • 批准号:
    10252395
  • 财政年份:
    2020
  • 资助金额:
    $ 207.71万
  • 项目类别:
Natural History of Viral Induced Airway Dysfunction and Asthma in Minority Children
少数民族儿童病毒引起的气道功能障碍和哮喘的自然史
  • 批准号:
    10369849
  • 财政年份:
    2018
  • 资助金额:
    $ 207.71万
  • 项目类别:
Natural History of Viral Induced Airway Dysfunction and Asthma in Minority Children
少数民族儿童病毒引起的气道功能障碍和哮喘的自然史
  • 批准号:
    9790976
  • 财政年份:
    2018
  • 资助金额:
    $ 207.71万
  • 项目类别:
Transcriptomic and Pharmacogenetic Asthma Endotypes in Minority Children
少数民族儿童哮喘内型的转录组学和药物遗传学
  • 批准号:
    9219450
  • 财政年份:
    2017
  • 资助金额:
    $ 207.71万
  • 项目类别:
Transcriptomic and Pharmacogenetic Asthma Endotypes in Minority Children
少数民族儿童哮喘内型的转录组学和药物遗传学
  • 批准号:
    9493041
  • 财政年份:
    2017
  • 资助金额:
    $ 207.71万
  • 项目类别:
Transcriptomic and Pharmacogenetic Asthma Endotypes in Minority Children
少数民族儿童哮喘内型的转录组学和药物遗传学
  • 批准号:
    9925294
  • 财政年份:
    2017
  • 资助金额:
    $ 207.71万
  • 项目类别:
Genes, air pollution, and asthma severity in minority children
少数民族儿童的基因、空气污染和哮喘严重程度
  • 批准号:
    9265934
  • 财政年份:
    2016
  • 资助金额:
    $ 207.71万
  • 项目类别:
Genes, air pollution, and asthma severity in minority children
少数民族儿童的基因、空气污染和哮喘严重程度
  • 批准号:
    9569799
  • 财政年份:
    2016
  • 资助金额:
    $ 207.71万
  • 项目类别:
Genes, air pollution, and asthma severity in minority children
少数民族儿童的基因、空气污染和哮喘严重程度
  • 批准号:
    9076396
  • 财政年份:
    2016
  • 资助金额:
    $ 207.71万
  • 项目类别:
Gene-Environment Analyses of Early Life Exposures and Asthma in Ethnically Diverse Children
不同种族儿童早期生命暴露和哮喘的基因环境分析
  • 批准号:
    8976612
  • 财政年份:
    2014
  • 资助金额:
    $ 207.71万
  • 项目类别:

相似海外基金

Rational design of rapidly translatable, highly antigenic and novel recombinant immunogens to address deficiencies of current snakebite treatments
合理设计可快速翻译、高抗原性和新型重组免疫原,以解决当前蛇咬伤治疗的缺陷
  • 批准号:
    MR/S03398X/2
  • 财政年份:
    2024
  • 资助金额:
    $ 207.71万
  • 项目类别:
    Fellowship
Re-thinking drug nanocrystals as highly loaded vectors to address key unmet therapeutic challenges
重新思考药物纳米晶体作为高负载载体以解决关键的未满足的治疗挑战
  • 批准号:
    EP/Y001486/1
  • 财政年份:
    2024
  • 资助金额:
    $ 207.71万
  • 项目类别:
    Research Grant
CAREER: FEAST (Food Ecosystems And circularity for Sustainable Transformation) framework to address Hidden Hunger
职业:FEAST(食品生态系统和可持续转型循环)框架解决隐性饥饿
  • 批准号:
    2338423
  • 财政年份:
    2024
  • 资助金额:
    $ 207.71万
  • 项目类别:
    Continuing Grant
Metrology to address ion suppression in multimodal mass spectrometry imaging with application in oncology
计量学解决多模态质谱成像中的离子抑制问题及其在肿瘤学中的应用
  • 批准号:
    MR/X03657X/1
  • 财政年份:
    2024
  • 资助金额:
    $ 207.71万
  • 项目类别:
    Fellowship
CRII: SHF: A Novel Address Translation Architecture for Virtualized Clouds
CRII:SHF:一种用于虚拟化云的新型地址转换架构
  • 批准号:
    2348066
  • 财政年份:
    2024
  • 资助金额:
    $ 207.71万
  • 项目类别:
    Standard Grant
BIORETS: Convergence Research Experiences for Teachers in Synthetic and Systems Biology to Address Challenges in Food, Health, Energy, and Environment
BIORETS:合成和系统生物学教师的融合研究经验,以应对食品、健康、能源和环境方面的挑战
  • 批准号:
    2341402
  • 财政年份:
    2024
  • 资助金额:
    $ 207.71万
  • 项目类别:
    Standard Grant
The Abundance Project: Enhancing Cultural & Green Inclusion in Social Prescribing in Southwest London to Address Ethnic Inequalities in Mental Health
丰富项目:增强文化
  • 批准号:
    AH/Z505481/1
  • 财政年份:
    2024
  • 资助金额:
    $ 207.71万
  • 项目类别:
    Research Grant
ERAMET - Ecosystem for rapid adoption of modelling and simulation METhods to address regulatory needs in the development of orphan and paediatric medicines
ERAMET - 快速采用建模和模拟方法的生态系统,以满足孤儿药和儿科药物开发中的监管需求
  • 批准号:
    10107647
  • 财政年份:
    2024
  • 资助金额:
    $ 207.71万
  • 项目类别:
    EU-Funded
Ecosystem for rapid adoption of modelling and simulation METhods to address regulatory needs in the development of orphan and paediatric medicines
快速采用建模和模拟方法的生态系统,以满足孤儿药和儿科药物开发中的监管需求
  • 批准号:
    10106221
  • 财政年份:
    2024
  • 资助金额:
    $ 207.71万
  • 项目类别:
    EU-Funded
Recite: Building Research by Communities to Address Inequities through Expression
背诵:社区开展研究,通过表达解决不平等问题
  • 批准号:
    AH/Z505341/1
  • 财政年份:
    2024
  • 资助金额:
    $ 207.71万
  • 项目类别:
    Research Grant
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了